What does the future of your drug discovery program look like? Many industry leaders are finding themselves in uncharted waters: the science is more sophisticated than ever, producing paradigm-altering treatments. But, historically high R&D costs and low success rates has emphasized the need to identify drugs focused on translationally-relevant targets in the most cost and time efficient way.
How do you thrive in this new era? Join seasoned scientific advisor, John Montana, as he shares innovative ways to progress truly translational drug discovery projects in an increasingly complex and competitive environment. You’ll learn how to optimize your operations and build a new model for drug development that emphasizes collaboration and novel approaches to funding.
- John Montana, PhD, Corporate Vice President, Integrated Drug Development and Strategic Projects, Charles River